drugset / Trial / NCT01487226

Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer

NCT01487226 ↗

Phase 2 Unknown 69 enrolled Korean Gynecologic Oncology Group
NaSingle-groupOpen-labelTreatment

Summary

Purpose Primary endpoint * To evaluate the 3-year disease free survival Second endpoints * To evaluate the 3-year \& 5-year overall survival To analyze the toxicity and the quality of life

Timeline

Start
2008-01
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 50 mg/m2 —
Subject Paclitaxel Small molecule 175 mg/m2 —

Indications